Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma.

× No keyword cloud information.

11 in total

Review 1. Immunotherapies for hepatocellular carcinoma.

Authors: Josep M Llovet; Florian Castet; Mathias Heikenwalder; Mala K Maini; Vincenzo Mazzaferro; David J Pinato; Eli Pikarsky; Andrew X Zhu; Richard S Finn
Journal: Nat Rev Clin Oncol Date: 2021-11-11 Impact factor: 65.011

Review 2. Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma.

Authors: Yung-Yeh Su; Yi-Sheng Liu; Chin-Fu Hsiao; Chiun Hsu; Li-Tzong Chen
Journal: J Hepatocell Carcinoma Date: 2022-06-02

3. New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy.

Authors: Anil C Anand; Subrat K Acharya
Journal: J Clin Exp Hepatol Date: 2021-04-27

4. Circular RNA Circ-0003006 Promotes Hepatocellular Carcinoma Proliferation and Metastasis Through Sponging miR-542-3p and Regulating HIF-1A.

Authors: Qiang Tu; Xiaoxiang You; Jun He; Xuguang Hu; Changji Xie; Guohui Xu
Journal: Cancer Manag Res Date: 2021-10-13 Impact factor: 3.989

5. Lactate promotes the growth of patient-derived organoids from hepatopancreatobiliary cancers via ENO1/HIF1α pathway and does not affect their drug sensitivities.

Authors: Zhiwei Wang; Yuanquan Yu; Peiyao Wu; Qinghuang Ye; Yinghao Guo; Xiaoxiao Zhang; Longfu Xi; Qi Li; Yun Jin; Donger Zhou; Yan Luo; Shuyou Peng; Jiangtao Li
Journal: Cell Death Discov Date: 2022-04-20

Review 6. Neoadjuvant Immunotherapy for Hepatocellular Carcinoma.

Authors: Thomas U Marron; Myron Schwartz; Virginia Corbett; Miriam Merad
Journal: J Hepatocell Carcinoma Date: 2022-06-30

Review 7. Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC.

Authors: Luca Marzi; Andrea Mega; Stefano Gitto; Filippo Pelizzaro; Andreas Seeber; Gilbert Spizzo
Journal: Cancers (Basel) Date: 2022-07-08 Impact factor: 6.575

Review 8. Neoadjuvant Therapy for Hepatocellular Carcinoma.

Authors: Zongyi Yin; Dongying Chen; Shuang Liang; Xiaowu Li
Journal: J Hepatocell Carcinoma Date: 2022-08-31

9. Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients.

Authors: Xingjie Gao; Chunyan Zhao; Nan Zhang; Xiaoteng Cui; Yuanyuan Ren; Chao Su; Shaoyuan Wu; Zhi Yao; Jie Yang
Journal: BMC Cancer Date: 2021-07-08 Impact factor: 4.430

10. High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma.

Authors: Yong-Guang Wei; Cheng-Kun Yang; Zhong-Liu Wei; Xi-Wen Liao; Yong-Fei He; Xin Zhou; Hua-Sheng Huang; Chen-Lu Lan; Chuang-Ye Han; Tao Peng
Journal: Int J Gen Med Date: 2022-01-14